Digital Garage’s Capital and Business Alliance Partner, Welby is Approved for Listing on the TSE’s Mothers Section

Welby, Inc. (HQ: Tokyo; CEO: Takeru Hiki; Welby) , a capital and business alliance partner of Digital Garage, Inc. (TSE first section: 4819; HQ: Tokyo; Representative Director, President Executive Officer and Group CEO: Kaoru Hayashi; DG) , is approved for listing on the Tokyo Stock Exchange’s Mothers section.

DG and Welby with its capital and business alliance from the past, have developed projects through DG Lab’s BioHealth team and the Biomedical Project Office related to each field. As one facet of the alliance, Joi Ito (DG Board of Directors Member and Co-Founder) serves as a Welby advisor. Through joint development with Welby, DG builds a PHR platform involving preventative medicine and health points with implementation of DG Lab’s blockchain and AI technologies. In the future, PHR will be linked with local governments, national and health insurance, medical institutions, pharmaceutical companies, and health-related business operators to build a person-centered health and medical data platform.

DG will also build services and infrastructure for not only medical care and caregiving, but also chronic diseases and preventative medicine with the aim of making biotechnology and healthcare-related businesses into a new leading businesses initiated by the capital and business alliance with Welby.

【About PHR】
Short for “Personal Health Record.” A set of personal health and medical information managed electronically by individuals.

【About Welby, Inc.】https://welby.jp/en/
Welby is a leading company that launched its personal health record (PHR) platform services in 2011. It provides PHR platform services for “support for continuation of treatment” and “facilitation of self-management” for patients with various chronic diseases. Welby My Karte, one of its PHR platform services, is a smartphone app to help patients of lifestyle-related diseases such as diabetes and hypertension, and potential patients of the lifestyle-related disease manage their information including blood sugar level and blood pressure. It also jointly plans many PHR platform services that are operated by Welby with leading pharmaceutical companies. Welby provides PHR platform services in a wide range of fields including lifestyle diseases, oncology, central nervous system, autoimmune disorders, and rare diseases. With its vision to “Empower the Patients,” Welby will keep leading Japanese PHR platform services for patient-focused medical care.